Abraxis BioScience Financial Statements
Abraxis BioScience Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Abraxis BioScience Income Statement
| 2008 | 2007* | 1998 | |
|---|---|---|---|
| Revenue ($ mil.) | 345.3 | 333.7 | 66.5 |
| Gross Profit ($ mil.) | 306.2 | 299.2 | 17.7 |
| Operating Income ($ mil.) | (278.5) | (49.4) | 0.1 |
| Total Net Income ($ mil.) | (276.8) | (41.6) | (0.5) |
| Diluted EPS (Net Income) | (6.91) | (1.04) | -- |
- * Irregular reporting interval
Abraxis BioScience Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 96.6 | 85.1 | 72.6 |
| Gross Profit ($ mil.) | 76.9 | 70.5 | 63.5 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (37.7) | (23.4) | (23.3) |
| Diluted EPS (Net Income) | (0.94) | (0.58) | (0.57) |
Abraxis BioScience Stock Quote & Chart
11/09/09 10:37:58 EST •
NASDAQ •
34.90
•
 +0.4700
•
+1.3651 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Abraxis BioScience Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.87 | 7.49 | 7.00 |
| Price/Earnings Ratio | (5.46) | 92.59 | 25.45 |
| Price/Book Ratio | 1.50 | 3.46 | 6.74 |
| Price/Cash Flow Ratio | (4.59) | 41.15 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Abraxis BioScience Financial Ratios
Abraxis BioScience Competitive Intelligence
| Acusphere | Bristol-Myers Squibb | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2.7 | 20,597.0 | 40,057.0 |
| Employees | 118 | 35,000 | 98,213 |
| Market Cap ($ mil.) | 4.1 | 44,572.1 | 97,482.8 |
Competitive Landscape
